Simplified Assessment of Antiretroviral Adherence and Prediction of Virological Efficacy in HIV-Infected Patients in Cambodia

Table 1

Description of the tools used to assess adherence.

	𝑁(%)
HAART dose missed in the last four days*
Yes	5 (2)
No	252 (98)
Dose delayed by >2 hours in the last four days*
Yes	22 (8.5)
No	235 (91.5)
HAART dose missed the previous weekend*
Yes	17 (6.6)
No	240 (93.4)
Self-report questionnaire (combining the above three items)*
At least one missed HAART dose	34 (13.2)
100% adherent	223 (86.8)
Visual analog scale*
<9	11 (4.3)
9	62 (24.1)
10	184 (71.6)
Antiretroviral drug concentrations (in ng/mL)
<1000 for EFV or <3000 for NVP	18 (7)
≥1000 for EFV or ≥3000 for NVP	241 (93)
Macrocytosis (MCV >100 fL)^**
No	23 (9.1)
Yes	229 (90.9)

*Available for 257 patients, ^**Available for 252 patients.